000			01304 a2200289 4500
005			20250515145201.0
264		0	_c20081217
008			200812s 0 0 eng d
022			_a1537-6591
024	7		_a10.1086/591428 _2doi
040			_aNLM _beng _cNLM
100	1		_aBoucher, Helen W
245	0	0	_aIs it possible to blind a trial for community-acquired pneumonia? _h[electronic resource]
260			_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cDec 2008
300			_aS210-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAnti-Bacterial Agents _xadverse effects
650	0	4	_aCommunity-Acquired Infections _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aHumans
650	0	4	_aPneumonia, Bacterial _xdrug therapy
650	0	4	_aRandomized Controlled Trials as Topic _xmethods
650	0	4	_aTreatment Outcome
773	0		_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 47 Suppl 3 _gp. S210-5
856	4	0	_uhttps://doi.org/10.1086/591428 _zAvailable from publisher's website
999			_c18447495 _d18447495